Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Bazedoxifene and conjugated estrogens
DRUG
2 trials
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
, University of Kansas Medical Center
Conditions
Breast Cancer
Postmenopause
Risk Reduction
Phase 1
Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women
Completed
NCT00706225
Wyeth is now a wholly owned subsidiary of Pfizer
Postmenopause
Start: 2008-06-30
End: 2008-07-31
Updated: 2010-09-23
Phase 2
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Active, not recruiting
NCT04821141
University of Kansas Medical Center
Breast Cancer, Risk Reduction
Start: 2021-12-14
End: 2027-07-31
Target: 120
Updated: 2025-10-29
Related Papers
Abstract PO2-08-10: Effect of 6 months of bazedoxifene + conjugated estrogens on body composition and insulin resistance
Cancer Research
2024-05-02